Despite warnings, potentially inappropriate CNS-active medications are commonly prescribed to older adults — especially those with cognitive impairment — highlighting missed opportunities for safer ...

Antidepressants increase the risk of suicidal thoughts and behaviors in pediatric and young adult patients in short-term studies. Closely monitor all antidepressant-treated patients for clinical ...

DENVER, CO / ACCESS Newswire / January 20, 2026 / Aytu BioPharma, Inc. (the "Company" or "Aytu") (Nasdaq:AYTU), a pharmaceutical company focused on advancing innovative medicines for complex central ...

Delivering therapies to the brain remains a major challenge due to the limited permeability of the blood-brain barrier. In a ...

Development of effective medications for central nervous system (CNS) disorders has long been plagued by a high failure rate in clinical trials. One ...

PRESS RELEASEAB SCIENCE RECEIVES JAPANESE PATENT PROTECTION FOR THE USE OF MASITINIB IN PROGRESSIVE FORMS OF MULTIPLE SCLEROSIS (MS) UNTIL ...

DENVER, CO / ACCESS Newswire / January 20, 2026 / Aytu BioPharma, Inc. (the "Company" or "Aytu") (Nasdaq:AYTU), a pharmaceutical company focused on advancing innovative medicines for complex central n ...

EXXUA addresses frequent causes of treatment discontinuation with first-line SSRIs and SNRIsNow commercially available through retail pharmacies and participating Aytu RxConnect pharmacies to support ...

As the one-year mark of his second presidential term approaches, controversy clings to President Donald Trump and he clings ...

Engine Ventures, led by Katie Rae ’97, backs science-intensive innovation, including clean energy, quantum computing, and ...

Chengdu Zenitar Biomedical Technology, a Chinese late clinical-stage biotech company, has filed for an initial public offering (IPO) on the main board of the Hong Kong stock exchange after the ...

Last fall, the number of new international undergraduates fell by 25 percent compared to the previous year. That drop poses ...